These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16095509)

  • 21. Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
    Santos AH; Casey MJ; Xuerong W; Womer KL
    Transplantation; 2017 Feb; 101(2):377-386. PubMed ID: 28121742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of sirolimus regimens in 65-year-old and older kidney transplant recipients: a registry-based observational study.
    Santos AH; Chen C; Alquadan K; Wen X
    Int Urol Nephrol; 2019 Nov; 51(11):2063-2072. PubMed ID: 31385180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival.
    Yang A; Wang B
    Am J Ther; 2015; 22(2):98-104. PubMed ID: 23921809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.
    Bunnapradist S; Takemoto SK
    Transplant Proc; 2003 Nov; 35(7):2407-8. PubMed ID: 14611971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.
    Chang GJ; Mahanty HD; Vincenti F; Freise CE; Roberts JP; Ascher NL; Stock PG; Hirose R
    Clin Transplant; 2000 Dec; 14(6):550-4. PubMed ID: 11127307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study.
    Claes K; Meier-Kriesche HU; Schold JD; Vanrenterghem Y; Halloran PF; Ekberg H
    Nephrol Dial Transplant; 2012 Feb; 27(2):850-7. PubMed ID: 21617197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial.
    Weir MR; Mulgaonkar S; Chan L; Shidban H; Waid TH; Preston D; Kalil RN; Pearson TC
    Kidney Int; 2011 Apr; 79(8):897-907. PubMed ID: 21191361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive treatment and progression of histologic lesions in kidney allografts.
    Morales JM
    Kidney Int Suppl; 2005 Dec; (99):S124-30. PubMed ID: 16336565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
    Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M
    Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late conversion of tacrolimus to sirolimus in a prednisone-free immunosuppression regimen in renal transplant patients.
    Chhabra D; Grafals M; Cabral B; Leventhal J; Parker M; Gallon L
    Clin Transplant; 2010; 24(2):199-206. PubMed ID: 19659511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.
    Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Fernandes FB; Casarini DE; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Feb; 23(1):137-45. PubMed ID: 19267777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I
    Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation.
    Hamdy AF; El-Agroudy AE; Bakr MA; Mostafa A; El-Baz M; El-Shahawy el-M; Ghoneim MA
    Am J Transplant; 2005 Oct; 5(10):2531-8. PubMed ID: 16162204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
    Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.
    Kobashigawa JA; Miller LW; Russell SD; Ewald GA; Zucker MJ; Goldberg LR; Eisen HJ; Salm K; Tolzman D; Gao J; Fitzsimmons W; First R;
    Am J Transplant; 2006 Jun; 6(6):1377-86. PubMed ID: 16686761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.
    Sampaio EL; Pinheiro-Machado PG; Garcia R; Felipe CR; Park SI; Casarini DE; Moreira S; Franco MF; Tedesco-Silva H; Medina-Pestana JO
    Clin Transplant; 2008; 22(2):141-9. PubMed ID: 18339132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.